2 PA PA-FORMULA
Dead / Cancelled — Cancelled — Section 8 (as of 01 Dec 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86771138
- Registration number
- 5205592
- Mark type
- Word mark
- Filed
- 28 Sept 2015
- Published for opposition
- 11 Oct 2016
- Registered
- 16 May 2017
- Attorney of record
- Ziwen Zhu
Goods and services
- Class 005 — Pharmaceuticals: Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional food additives for medical purposes for human consumption or animals in the nature of natural food extracts derived from soybean; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases
Owner
- GOLDEN BIOTECHNOLOGY CORPORATION, New Taipei City, TW
- GOLDEN BIOTECHNOLOGY CORPORATION, New Taipei City, TW
- GOLDEN BIOTECHNOLOGY CORPORATION, New Taipei City, TW
Prosecution history
- 01 Dec 2023 — CANCELLED SEC. 8 (6-YR)
- 16 May 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 May 2017 — REGISTERED-PRINCIPAL REGISTER
- 11 Apr 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Apr 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Apr 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Mar 2017 — USE AMENDMENT FILED
- 07 Apr 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Mar 2017 — TEAS STATEMENT OF USE RECEIVED
- 06 Dec 2016 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Oct 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Oct 2016 — PUBLISHED FOR OPPOSITION
- 21 Sept 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Sept 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 06 Sept 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER